CD4 and metabolic dysfunction-associated steatotic liver disease: Interestingly, the level of IL-10 [MFI in CD4+] and IL-10 [MFI in CD4+CD25+] differentiated patients with simple steatosis in early MASLD from advanced MASLD patients (p < 0.01, p < 0.02, respectively).